SuperworthCamp4 Therapeutics market cap CAMP
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $207.1M
- Highest close in our data
- $341.4M
- Aug 2026
Camp4 Therapeutics is worth $207.1M at the close on Oct 23, 2026, at $3.30 a share.
That is up 176% over the last year.
Its highest close in our data was $341.4M in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $207.1M | $164.1M | $341.4M | −26% |
| 2025 | $279.4M | $28.2M | $304.3M | +155% |
| 2024 | $109.5M | $96.6M | $157.5M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Camp4 Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| CAMPCamp4 Therapeutics | $207.1M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| LFVNLifevantage | $73.4M |
| CRMDCorMedix | $611.9M |
| SPROSpero Therapeutics | $64.6M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| Peer median | $570.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Camp4 Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.